Table 2.
Baseline characteristics of patients with acute kidney injury who required renal replacement therapy
| Anuric AKI (n=43) | Oliguric AKI (n=57) | Nonoliguric AKI (n=103) | P⁎ | P1† | P2‡ | |
|---|---|---|---|---|---|---|
| Age (y) | 59.4±19.9 | 64.0±14.6 | 66.1±14.6 | 0.072 | 0.071 | 0.058 |
| Male sex | 62.8 | 49.1 | 63.1 | 0.195 | 0.256 | 0.605 |
| Baseline Cr (mg/dL) | 1.01±0.24 | 1.03±0.34 | 1.12±0.36 | 0.163 | 0.057 | 0.269 |
| Baseline eGFR (mL/min/1.73 m2) | 75.1±21.0 | 73.9±23.6 | 70.4±24.6 | 0.514 | 0.256 | 0.433 |
| Comorbidities | ||||||
| CKD | 26.3 | 31.4 | 48.0 | 0.028 | 0.011 | 0.046 |
| CKD(3) | 21.1 | 26.9 | 42.9 | 0.024 | 0.009 | 0.056 |
| Diabetes | 22.0 | 36.8 | 42.6 | 0.069 | 0.105 | 0.030 |
| Liver cirrhosis | 5.0 | 17.0 | 6.0 | 0.047 | 0.205 | 0.532 |
| Malignancy | 26.2 | 21.4 | 18.8 | 0.614 | 0.488 | 0.396 |
Data are presented as mean±SD values or %.
ANOVA, analysis of variance; AKI, acute kidney injury; CKD, chronic kidney disease; Cr, creatinine; eGFR, estimated glomerular filtration rate; RRT, renal replacement therapy; SD, standard deviation.
⁎
P, obtained by one-way ANOVA or χ2 test among three groups.
†
P1, obtained by Student t test or Fisher’s exact test between two groups (anuric+oliguric vs. nonoliguric).
‡
P2, between two groups (anuric vs. oliguric+nonoliguric).